Single-Cell Transcriptomic Analysis Reveals Reduction of Cytotoxic NK Cells in a Subset of Newly Diagnosed Multiple Myeloma Patients Impacting Outcome after Daratumumab Therapy

作者
Sabrin Tahri,Madelon M.E. de Jong,Cathelijne Fokkema,Natalie Papazian,Zoltán Kellermayer,Michael Vermeulen,Mark van Duin,Pieter van de Woestijne,Kazem Nasserinejad,Elona Saraci,Mattia D’Agostino,Francesca Gay,Vincent H. J. van der Velden,Niels W.C.J. van de Donk,Annemiek Broijl,Pieter Sonneveld,Sonja Zweegman,Tom Cupedo
出处
期刊:Blood [Elsevier BV]
卷期号:140 (Supplement 1): 9982-9984 被引量:2
标识
DOI:10.1182/blood-2022-164812
摘要

Introduction Anti-CD38 antibody-based therapies in multiple myeloma (MM) rely to a large degree on natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (ADCC). Classically, NK cells are divided into cytotoxic CD56dim NK cells, important for ADCC, and cytokine-producing CD56bright NK cells. Accumulating evidence in other types of cancer suggests that alterations in the balance between CD56dim and CD56bright NK cells is associated with inferior clinical outcome. We hypothesized that changes in NK cell subset composition in the MM microenvironment would impact therapy-responses during NK cell-driven immunotherapies. Here, we used single-cell RNA sequencing and flow cytometry to investigate the heterogeneity of the NK cell compartment in the bone marrow (BM) of newly diagnosed MM (NDMM) patients, and the effects of altered NK cell subset composition on therapy response in patients undergoing first-line daratumumab-containing therapy. Results We performed single-cell RNA sequencing of the BM CD38+ immune cell compartment from 19 NDMM patients. NK cells were identified in silico resulting in a single-cell transcriptomic dataset of 24,664 NK cells. UMAP dimensionality reduction identified 5 transcriptomic distinct NK cell clusters, present in all NDMM patients. Conventional CD56bright and CD56dim NK cells were identified by increased transcription of GZMK or GZMB, respectively. To study the balance of cytotoxic vs cytokine-producing NK cells in MM we compared the relative abundance of cytokine-producing GZMK+CD56bright NK cells vs cytotoxic GZMB+CD56dim NK cells in individual patients in our cohort. The MM BM was characterized by heterogeneity in the ratio of cytotoxic vs cytokine-producing NK cell cluster composition, in which most patients had a predominance of cytotoxic NK cells, while a subset of patients presented with a relative decrease in cytotoxic NK cell clusters (Figure 1A). The reduction in cytotoxic NK cell subsets in this patient subgroup was reflected in an altered overall transcriptome of the total BM NK cell population, with enrichment for inhibitory receptors such as KLRB1 and KLRC1, and a relative loss of activating receptors such as FCGR3A (CD16), NCR3 (NKp30) and CD226 (DNAM-1), and cytotoxic effector genes including NKG7 and GNLY. To define the relative abundance of a reduced cytotoxic NK cell potential in NDMM patients, we performed flow cytometric analyses of 246 NDMM patients from 2 independent clinical cohorts. This revealed a reduced frequency of cytotoxic CD56dim NK cells, defined as < 90% CD56dim NK cells, in 17.9 % of 162 transplant-eligible treatment-naïve NDMM and in 28.6% of 84 treatment-naïve frail or unfit transplant ineligible MM patients. To test whether such relative decrease in cytotoxic NK cells would impact responses to daratumumab, we tested the association of BM NK cell composition with clinical outcome in the context of first-line daratumumab therapy in a cohort of frail NDMM patients ineligible for transplant from the HO143 trial (n=43). NDMM patients with reduced frequencies of BM cytotoxic NK cells presented with significantly shorter progression-free survival (PFS) (Figure 1B, PFS, p = 0.031, log-rank test), while OS was not impacted (p = 0.18, log-rank test). Univariate Cox regression analyses confirmed the correlation between reduced frequencies of CD56dim NK cells in the BM and significantly shorter PFS (hazard ratio (HR) 1.38; 95% confidence interval: 1.057 - 1.803; P = 0.018). Whether reduced frequencies of cytotoxic CD56dim NK cells affect outcome in transplant-eligible patients warrants additional study. Conclusion Here we show that about 20% of NDMM patients have an altered BM NK cell composition with a relative reduction in cytotoxic NK cells. Such altered NK cell composition correlates with significantly shorter PFS following daratumumab-containing therapy in a cohort of frail NDMM patients. Our data suggest that defining BM NK cell composition could stratify patients and identify a subgroup less likely to benefit from therapies driven by NK cell-mediated ADCC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Shulug完成签到 ,获得积分10
刚刚
李可以完成签到 ,获得积分10
2秒前
weven完成签到 ,获得积分10
6秒前
foyefeng完成签到,获得积分10
8秒前
lllll完成签到 ,获得积分10
22秒前
lzr完成签到 ,获得积分10
22秒前
友好的晓曼完成签到,获得积分10
24秒前
白鱼neko完成签到 ,获得积分10
25秒前
木卫二完成签到 ,获得积分10
27秒前
xiaoxiao完成签到 ,获得积分10
28秒前
momo完成签到 ,获得积分10
29秒前
风格完成签到,获得积分10
38秒前
38秒前
水煮电吹风的应助被雪山飞龙采纳,获得10
39秒前
醉酒当歌完成签到 ,获得积分10
40秒前
侯子完成签到 ,获得积分10
40秒前
追寻微笑完成签到 ,获得积分10
40秒前
勤劳的唇膏完成签到,获得积分10
44秒前
taowenquan完成签到 ,获得积分10
51秒前
旅行者N0501完成签到,获得积分10
53秒前
灵巧的长颈鹿完成签到,获得积分10
59秒前
怼怼完成签到 ,获得积分10
1分钟前
nikki完成签到 ,获得积分10
1分钟前
马伯乐完成签到 ,获得积分10
1分钟前
Hello的应助被豆豆采纳,获得10
1分钟前
1分钟前
动人的冷霜完成签到,获得积分10
1分钟前
迅速的新竹完成签到,获得积分10
1分钟前
Peiqi的应助被雪山飞龙采纳,获得10
1分钟前
1分钟前
蓝精灵完成签到,获得积分10
1分钟前
yuki完成签到 ,获得积分10
1分钟前
漾漾的羊完成签到 ,获得积分10
1分钟前
dianeil完成签到,获得积分10
1分钟前
王不凡完成签到 ,获得积分10
1分钟前
LWJ完成签到 ,获得积分10
1分钟前
竹舍翁暮雨君完成签到 ,获得积分10
1分钟前
机智的孤兰完成签到 ,获得积分10
1分钟前
拼搏忆文完成签到,获得积分10
1分钟前
康康舞曲完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180053
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808682
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012